Talis Biomedical Corp
TLISDelisted Sep 20, 2024- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001584751
Talis Biomedical Corp was delisted on Sep 20, 2024; its insiders filed their last Form 4 on Sep 9, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $6.84M in total; Greenlight Capital was the only superinvestor holding it.
Q1 2023 vs. Q4 2022
How the institutions holding Talis Biomedical Corp changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 27 | 22 | −5 |
| Shares | 12.6M | 11.8M | −821.0K (−6.5%) |
| Value | $5.60M | $5.76M | +$157.2K (+2.8%) |
New holders (1)
Institutions that held Talis Biomedical Corp at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tower Research Capital LLC (TRC) | 527 | $0 | 0.00% |
Sold out (6)
Institutions that held Talis Biomedical Corp at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Citadel Advisors LLC | 95,060 | $42.3K |
| Jane Street Group, LLC | 32,075 | $14.3K |
| Susquehanna International Group, LLP | 19,409 | $8.64K |
| Virtu Financial LLC | 10,760 | $5.00K |
| Bank of America Corp | 40 | $18 |
| Simplex Trading, LLC | 164 | $0 |